drugset / Trial / NCT02952222

The Synergistic Effect of Dexmedetomidine on Propofol for Sedation for Pediatric Endoscopy

NCT02952222 ↗

Phase 4 Completed 39 enrolled Keira Mason
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary aim of this study is to compare the propofol requirements of children who receive propofol with that of children who receive dexmedetomidine prior to propofol, for sedation for upper and lower endoscopic procedures.

Timeline

Start
2018-05-11
Primary completion
2019-09-11
Completion
2019-09-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.15 ug/kg —
Comparator Propofol Small molecule 200 ug/kg Intravenous

Indications

No indication recorded.